Future directions Available research on AOX therapy is surrounded by several limitations and biases, including small sample sizes, heterogenous patient populations and inclusion criteria, poor study designs, and inconsistent reporting of clinical outcomes
In some embodiments, otic formulations described herein prolong the residence time of an active agent in the inner ear and provide a stable drug exposure profile
The ampoule delivers rapid saturation of tissues with active BPC-157, which is essential during acute physical stress, injuries, or the initial stages of a protocol requiring a stronger therapeutic response
After a noticeable improvement in skin tone, the frequency is reduced to once a week for maintenance
Rapid escalation correlates with more severe GI side effects, higher discontinuation rates, and no improvement in long-term outcomes